Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

177 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 43.1M shares of 58.9M outstanding shares and own 73.29% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.1M shares), RENAISSANCE TECHNOLOGIES LLC (3.85M shares), VANGUARD GROUP INC (3.51M shares), DIMENSIONAL FUND ADVISORS LP (2.49M shares), TANG CAPITAL MANAGEMENT LLC (2.35M shares), ACADIAN ASSET MANAGEMENT LLC (1.9M shares), GEODE CAPITAL MANAGEMENT, LLC (1.45M shares), MORGAN STANLEY (1.34M shares), STATE STREET CORP (1.18M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.04M shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.